Artificial intelligence (AI) is not an unknown concept in healthcare. For years, forward-thinking healthcare providers have used technology to improve care for people suffering from sleep problems, eye illness, cancer, and even COVID-19.
The technology has sparked interest in clinical care, with promises of speedier illness detection, expanded access to care in underprivileged or emerging areas, reduced EHR use burden, and more.
However, integrating AI into revenue cycle management could be the biggest break in healthcare for the technology.
The healthcare revenue cycle, for example, is a high-transaction setting with established rules that AI excels at.
The revenue cycle has a lot of tagged data, which implies that values are assigned to data points to signify particular occurrences, such as why a claim was refused or the diagnostic characteristics.
AI can use algorithms to imitate intelligent human behavior and plan future actions to achieve a favorable end. This is in contrast to other emerging technologies like machine learning and robotic process automation, which, like AI, may spot patterns but are more concerned with improving accuracy than delivering good results. These other technologies have limited or no ability to plan actions beyond the current task.
As a result, AI’s “intelligence” can effectively address the most pressing revenue cycle management issues, such as prior authorizations, claim status checks, and out-of-pocket cost estimates, while simultaneously getting the information that requires human intervention to the right person at the right time.
Getting Confused From The Noise
Providers are inundated with offers for technologies that claim to use cutting-edge AI to solve some of the revenue cycle’s most vexing problems while maximizing revenue capture and integrity.
Despite the apparent increase in product offerings and the revenue cycle’s readiness for automation, AI adoption for revenue cycle management is not as widespread as one might imagine.
Providers are preparing for a larger-scale adoption. According to a recent poll of C-suite executives, less than half of healthcare businesses (44%) are now using AI in some form or another, but 88 percent expect widespread adoption within the next five years. According to respondents, these implementations would influence revenue integrity, clinical documentation improvement, coding, and other aspects of the revenue cycle.
However, getting everyone on board with spanning the chasm could be difficult.